Patents by Inventor Begoña Duarte Lopez

Begoña Duarte Lopez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions Comprising Dimethyl Fumarate
    Publication number: 20210330628
    Abstract: Pharmaceutical compositions are described comprising (a) dimethyl fumarate, (b) a diluent selected from monosaccharides, disaccharides, starch and starch derivatives, calcium and magnesium inorganic salts, sugar alcohols, and mixtures thereof, (c) microcrystalline cellulose and (d) croscarmellose sodium, wherein the dimethyl fumarate is not covered with a gastro-resistant coating. These compositions are intended for the treatment of some inflammatory autoimmune diseases or disorders.
    Type: Application
    Filed: May 11, 2021
    Publication date: October 28, 2021
    Inventors: Maria PLANELLS JIMENEZ, Begoña DUARTE LOPEZ, Pere GUIRO COLL
  • PHARMACEUTICAL COMPOSITIONS COMPRISING DIMETHYL FUMARATE
    Publication number: 20160310457
    Abstract: Pharmaceutical compositions are described comprising (a) dimethyl fumarate, (b) a diluent selected from monosaccharides, disaccharides, starch, and starch derivatives, calcium and magnesium inorganic salts, sugar alcohols, and mixtures thereof, (c) microcrystalline cellulose and (d) croscarmellose sodium, wherein the dimethyl fumarate is not covered with a gastro-resistant coating. These compositions are intended for the treatment of some inflammatory autoimmune diseases or disorders.
    Type: Application
    Filed: December 5, 2014
    Publication date: October 27, 2016
    Applicant: Almirall, S.A.
    Inventors: Maria PLANELLS JIMENEZ, Begoña DUARTE LOPEZ, Pere GUIRO COLL
  • LIQUID PHARMACEUTICAL COMPOSITIONS
    Publication number: 20120232123
    Abstract: Aqueous liquid pharmaceutical composition comprising a) almotriptan and b) at least one compound selected from i) 1?-methyl-5-((pyrrolidin-1-ylsulfonyl)methyl)spiro[indoline-3,3?-pyrrolidin]-2-ol, and ii) 3-(2-(dimethylamino)ethyl)-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-2-ol.
    Type: Application
    Filed: November 19, 2010
    Publication date: September 13, 2012
    Inventors: Begoña Duarte Lopez, Pere Guiro Coll
  • LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING A TRIPTAN COMPOUND AND XYLITOL
    Publication number: 20110257228
    Abstract: The present disclosure relates to aqueous liquid pharmaceutical compositions comprising a) at least one triptan compound, pharmaceutically acceptable salts or hydrates thereof, and b) xylitol.
    Type: Application
    Filed: December 15, 2009
    Publication date: October 20, 2011
    Inventors: Begoña Duarte Lopez, Pere Guiro Coll, Antoni Masso Carbonell